Corient Private Wealth’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Corient Private Wealth’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,862	Closed	-$378K	–	2561
2025 Q1	$378K	Buy	+2,862	New	+$357K	﹤0.01%	1736

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Corient Private Wealth's ITCI Position: Q2 2025 in Review

Corient Private Wealth sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 2,862 shares — an estimated $378K sold.

Corient Private Wealth first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $378K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Corient Private Wealth reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Corient Private Wealth sold 2,862 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $378K.
Corient Private Wealth first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Corient Private Wealth's Intra-Cellular Therapies Inc. position peaked at $378K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Corient Private Wealth's 13F filing for Q2 2025, filed 15 Aug 2025.